Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Roche Products Limited
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 23/12/2011
PIL Avastin 25mg/ml concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Change to side-effects
Updated on 02/12/2011 and displayed until 23/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 05/08/2011 and displayed until 02/12/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 08/07/2011 and displayed until 05/08/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 07/03/2011 and displayed until 08/07/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 11/01/2011 and displayed until 07/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 08/09/2010 and displayed until 11/01/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 20/07/2010 and displayed until 08/09/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/06/2010 and displayed until 20/07/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/01/2010 and displayed until 10/06/2010
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to Further Information section
  • Change to storage instructions
  • Change to side-effects
Updated on 22/01/2010 and displayed until 22/01/2010
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to Further Information section
  • Change to storage instructions
  • Change to side-effects
Updated on 30/07/2009 and displayed until 22/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/04/2009 and displayed until 30/07/2009
Reasons for adding or updating:
  • Change of contra-indications
Updated on 11/09/2008 and displayed until 01/04/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/02/2008 and displayed until 11/09/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 29/01/2008 and displayed until 12/02/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 12/12/2007 and displayed until 29/01/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 12/11/2007 and displayed until 12/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/09/2007 and displayed until 12/11/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 03/05/2007 and displayed until 25/09/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 13/04/2007 and displayed until 03/05/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 19/07/2006 and displayed until 13/04/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 11/01/2006 and displayed until 19/07/2006
Reasons for adding or updating:
  • Change to date of revision
  • Improved Electronic Presentation
Updated on 14/03/2005 and displayed until 11/01/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  bevacizumab